 | • レポートコード：D0GIR-00722 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、肺炎の世界市場を広く調査・分析し、今後の市場展望をまとめております。肺炎の種類別市場規模（薬物、ワクチン、酸素療法）、用途別市場規模（病院、外来手術センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Novartis、GlaxoSmithKline(GSK)、Merck、Eli Lilly、Sanofi ・地域別グローバル市場分析 2015年-2020年 ・肺炎の北米市場（アメリカ、カナダ、メキシコ） ・肺炎のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・肺炎のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・肺炎の南米市場（ブラジル、アルゼンチン） ・肺炎の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：薬物、ワクチン、酸素療法 ・用途別分析：病院、外来手術センター、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Pneumonia market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Pneumonia market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pneumonia market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pneumonia market has been segmented into:
Drugs
Vaccines
Oxygen Therapy
By Application, Pneumonia has been segmented into:
Hospitals
Ambulatory Surgical Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pneumonia market presented in the report. This section sheds light on the sales growth of different regional and country-level Pneumonia markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pneumonia market.
The report offers in-depth assessment of the growth and other aspects of the Pneumonia market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Pneumonia Market Share Analysis
Pneumonia competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pneumonia sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pneumonia sales, revenue and market share for each player covered in this report.
The major players covered in Pneumonia are:
Pfizer
Novartis
GlaxoSmithKline(GSK)
Merck
Eli Lilly
Sanofi
Table of Contents
1 Pneumonia Market Overview
1.1 Product Overview and Scope of Pneumonia
1.2 Classification of Pneumonia by Type
1.2.1 Global Pneumonia Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Pneumonia Revenue Market Share by Type in 2019
1.2.3 Drugs
1.2.4 Vaccines
1.2.5 Oxygen Therapy
1.3 Global Pneumonia Market by Application
1.3.1 Overview: Global Pneumonia Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Pneumonia Market by Regions
1.4.1 Global Pneumonia Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Pneumonia (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Pneumonia Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Pneumonia Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pneumonia Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Pneumonia Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pneumonia Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Pneumonia Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Pneumonia Revenue, Gross Margin and Market Share (2018-2019)
2.3 GlaxoSmithKline(GSK)
2.3.1 GlaxoSmithKline(GSK) Details
2.3.2 GlaxoSmithKline(GSK) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GlaxoSmithKline(GSK) SWOT Analysis
2.3.4 GlaxoSmithKline(GSK) Product and Services
2.3.5 GlaxoSmithKline(GSK) Pneumonia Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Pneumonia Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly SWOT Analysis
2.5.4 Eli Lilly Product and Services
2.5.5 Eli Lilly Pneumonia Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Pneumonia Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Pneumonia Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Pneumonia Players Market Share
3.2.2 Top 10 Pneumonia Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Pneumonia Revenue and Market Share by Regions
4.2 North America Pneumonia Revenue and Growth Rate (2015-2020)
4.3 Europe Pneumonia Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Pneumonia Revenue and Growth Rate (2015-2020)
4.5 South America Pneumonia Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Pneumonia Revenue and Growth Rate (2015-2020)
5 North America Pneumonia Revenue by Countries
5.1 North America Pneumonia Revenue by Countries (2015-2020)
5.2 USA Pneumonia Revenue and Growth Rate (2015-2020)
5.3 Canada Pneumonia Revenue and Growth Rate (2015-2020)
5.4 Mexico Pneumonia Revenue and Growth Rate (2015-2020)
6 Europe Pneumonia Revenue by Countries
6.1 Europe Pneumonia Revenue by Countries (2015-2020)
6.2 Germany Pneumonia Revenue and Growth Rate (2015-2020)
6.3 UK Pneumonia Revenue and Growth Rate (2015-2020)
6.4 France Pneumonia Revenue and Growth Rate (2015-2020)
6.5 Russia Pneumonia Revenue and Growth Rate (2015-2020)
6.6 Italy Pneumonia Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Pneumonia Revenue by Countries
7.1 Asia-Pacific Pneumonia Revenue by Countries (2015-2020)
7.2 China Pneumonia Revenue and Growth Rate (2015-2020)
7.3 Japan Pneumonia Revenue and Growth Rate (2015-2020)
7.4 Korea Pneumonia Revenue and Growth Rate (2015-2020)
7.5 India Pneumonia Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Pneumonia Revenue and Growth Rate (2015-2020)
8 South America Pneumonia Revenue by Countries
8.1 South America Pneumonia Revenue by Countries (2015-2020)
8.2 Brazil Pneumonia Revenue and Growth Rate (2015-2020)
8.3 Argentina Pneumonia Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Pneumonia by Countries
9.1 Middle East & Africa Pneumonia Revenue by Countries (2015-2020)
9.2 Saudi Arabia Pneumonia Revenue and Growth Rate (2015-2020)
9.3 UAE Pneumonia Revenue and Growth Rate (2015-2020)
9.4 Egypt Pneumonia Revenue and Growth Rate (2015-2020)
9.5 South Africa Pneumonia Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Pneumonia Revenue and Market Share by Type (2015-2020)
10.2 Global Pneumonia Market Forecast by Type (2019-2024)
10.3 Drugs Revenue Growth Rate (2015-2025)
10.4 Vaccines Revenue Growth Rate (2015-2025)
10.5 Oxygen Therapy Revenue Growth Rate (2015-2025)
11 Global Pneumonia Market Segment by Application
11.1 Global Pneumonia Revenue Market Share by Application (2015-2020)
11.2 Pneumonia Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Pneumonia Market Size Forecast (2021-2025)
12.1 Global Pneumonia Market Size Forecast (2021-2025)
12.2 Global Pneumonia Market Forecast by Regions (2021-2025)
12.3 North America Pneumonia Revenue Market Forecast (2021-2025)
12.4 Europe Pneumonia Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Pneumonia Revenue Market Forecast (2021-2025)
12.6 South America Pneumonia Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Pneumonia Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Pneumonia Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pneumonia by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pneumonia Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Pneumonia Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Pneumonia Major Business
Table 7. Pfizer Pneumonia Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Pneumonia Product and Solutions
Table 10. Pfizer Pneumonia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Novartis Corporate Information, Location and Competitors
Table 12. Novartis Pneumonia Major Business
Table 13. Novartis Pneumonia Total Revenue (USD Million) (2018-2019)
Table 14. Novartis SWOT Analysis
Table 15. Novartis Pneumonia Product and Solutions
Table 16. Novartis Pneumonia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. GlaxoSmithKline(GSK) Corporate Information, Location and Competitors
Table 18. GlaxoSmithKline(GSK) Pneumonia Major Business
Table 19. GlaxoSmithKline(GSK) Pneumonia Total Revenue (USD Million) (2017-2018)
Table 20. GlaxoSmithKline(GSK) SWOT Analysis
Table 21. GlaxoSmithKline(GSK) Pneumonia Product and Solutions
Table 22. GlaxoSmithKline(GSK) Pneumonia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck Corporate Information, Location and Competitors
Table 24. Merck Pneumonia Major Business
Table 25. Merck Pneumonia Total Revenue (USD Million) (2017-2018)
Table 26. Merck SWOT Analysis
Table 27. Merck Pneumonia Product and Solutions
Table 28. Merck Pneumonia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Eli Lilly Corporate Information, Location and Competitors
Table 30. Eli Lilly Pneumonia Major Business
Table 31. Eli Lilly Pneumonia Total Revenue (USD Million) (2017-2018)
Table 32. Eli Lilly SWOT Analysis
Table 33. Eli Lilly Pneumonia Product and Solutions
Table 34. Eli Lilly Pneumonia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Sanofi Corporate Information, Location and Competitors
Table 36. Sanofi Pneumonia Major Business
Table 37. Sanofi Pneumonia Total Revenue (USD Million) (2017-2018)
Table 38. Sanofi SWOT Analysis
Table 39. Sanofi Pneumonia Product and Solutions
Table 40. Sanofi Pneumonia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Pneumonia Revenue (Million USD) by Players (2015-2020)
Table 42. Global Pneumonia Revenue Share by Players (2015-2020)
Table 43. Global Pneumonia Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Pneumonia Revenue Market Share by Regions (2015-2020)
Table 45. North America Pneumonia Revenue by Countries (2015-2020)
Table 46. North America Pneumonia Revenue Market Share by Countries (2015-2020)
Table 47. Europe Pneumonia Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Pneumonia Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Pneumonia Revenue by Countries (2015-2020)
Table 50. South America Pneumonia Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Pneumonia Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Pneumonia Revenue Market Share by Countries (2015-2020)
Table 53. Global Pneumonia Revenue (Million USD) by Type (2015-2020)
Table 54. Global Pneumonia Revenue Share by Type (2015-2020)
Table 55. Global Pneumonia Revenue Forecast by Type (2021-2025)
Table 56. Global Pneumonia Revenue by Application (2015-2020)
Table 57. Global Pneumonia Revenue Share by Application (2015-2020)
Table 58. Global Pneumonia Revenue Forecast by Application (2021-2025)
Table 59. Global Pneumonia Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Pneumonia Picture
Figure 2. Global Pneumonia Revenue Market Share by Type in 2019
Figure 3. Drugs Picture
Figure 4. Vaccines Picture
Figure 5. Oxygen Therapy Picture
Figure 6. Pneumonia Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Ambulatory Surgical Centers Picture
Figure 9. Others Picture
Figure 10. Global Pneumonia Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Pneumonia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Pneumonia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Pneumonia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Pneumonia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Pneumonia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Pneumonia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Pneumonia Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Pneumonia Revenue Market Share in 2019
Figure 19. Global Top 10 Players Pneumonia Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Pneumonia Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Pneumonia Revenue Market Share by Regions (2015-2020)
Figure 23. Global Pneumonia Revenue Market Share by Regions in 2018
Figure 24. North America Pneumonia Revenue and Growth Rate (2015-2020)
Figure 25. Europe Pneumonia Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Pneumonia Revenue and Growth Rate (2015-2020)
Figure 27. South America Pneumonia Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Pneumonia Revenue and Growth Rate (2015-2020)
Figure 29. North America Pneumonia Revenue Market Share by Countries (2015-2020)
Figure 30. North America Pneumonia Revenue Market Share by Countries in 2019
Figure 31. USA Pneumonia Revenue and Growth Rate (2015-2020)
Figure 32. Canada Pneumonia Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Pneumonia Revenue and Growth Rate (2015-2020)
Figure 34. Europe Pneumonia Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Pneumonia Revenue Market Share by Countries in 2019
Figure 36. Germany Pneumonia Revenue and Growth Rate (2015-2020)
Figure 37. UK Pneumonia Revenue and Growth Rate (2015-2020)
Figure 38. France Pneumonia Revenue and Growth Rate (2015-2020)
Figure 39. Russia Pneumonia Revenue and Growth Rate (2015-2020)
Figure 40. Italy Pneumonia Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Pneumonia Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Pneumonia Revenue Market Share by Countries in 2019
Figure 43. China Pneumonia Revenue and Growth Rate (2015-2020)
Figure 44. Japan Pneumonia Revenue and Growth Rate (2015-2020)
Figure 45. Korea Pneumonia Revenue and Growth Rate (2015-2020)
Figure 46. India Pneumonia Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Pneumonia Revenue and Growth Rate (2015-2020)
Figure 48. South America Pneumonia Revenue Market Share by Countries (2015-2020)
Figure 49. South America Pneumonia Revenue Market Share by Countries in 2019
Figure 50. Brazil Pneumonia Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Pneumonia Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Pneumonia Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Pneumonia Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Pneumonia Revenue and Growth Rate (2015-2020)
Figure 55. UAE Pneumonia Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Pneumonia Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Pneumonia Revenue and Growth Rate (2015-2020)
Figure 58. Global Pneumonia Revenue Share by Type (2015-2020)
Figure 59. Global Pneumonia Revenue Share by Type in 2019
Figure 60. Global Pneumonia Market Share Forecast by Type (2021-2025)
Figure 61. Global Drugs Revenue Growth Rate (2015-2020)
Figure 62. Global Vaccines Revenue Growth Rate (2015-2020)
Figure 63. Global Oxygen Therapy Revenue Growth Rate (2015-2020)
Figure 64. Global Pneumonia Revenue Share by Application (2015-2020)
Figure 65. Global Pneumonia Revenue Share by Application in 2019
Figure 66. Global Pneumonia Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Pneumonia Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Pneumonia Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Pneumonia Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Pneumonia Revenue Market Forecast (2021-2025)
Figure 74. Europe Pneumonia Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Pneumonia Revenue Market Forecast (2021-2025)
Figure 76. South America Pneumonia Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Pneumonia Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
市中肺炎（CAP）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Community Acquired Pneumonia (CAP) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Community …- 院内感染管理の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Hospital Acquired Infection Control market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1179.1 million by 2025, from USD 1068.4 million in 2019. The …
- ビアペネムの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Biapenem market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 薬剤・ワクチン臨床試験の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Clinical Trials of Drugs and Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…
- セフェタメットピボキシル錠の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cefetamet Pivoxil Tablets market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cefetamet Pivoxil T…